Panel: Ai in scientific publications- where do we go from here

Session details:

• Navigate how pharma teams are actually using AI in medical communications today while navigating uncertainty, risk, and evolving industry expectations.
• Examine the growing tension between authors, journals, vendors, and companies as AI reshapes ownership, authorship, and intellectual contribution.
• Discuss how organizations are building guardrails around confidentiality, copyright, and data security without slowing innovation.
• Share practical frameworks for developing internal AI guidance and aligning legal, IT, medical, and agency partners on responsible use.